Hepatocyte growth factor in serum after injection of unfractionated and low molecular weight heparin in healthy individuals

British Journal of Haematology

Volumn 105, Issue 3, 1999, Pages 641-647

  Seidel, Carina ^a   Hjorth Hansen, Henrik ^a   Bendz, Bjørn ^b   Børset, Magne ^a   Sandset, Per Morten ^b   Hansen, John Bjarne ^c   Sundan, Anders ^a   Waage, Anders ^d  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Dalteparin; Heparin; Hepatocyte growth factor; Serum; Volunteers

Indexed keywords

DALTEPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTEOGLYCAN; SCATTER FACTOR;

ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG STABILITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0033063703     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01398.x     Document Type: Article

References (40)

1. Abildgaard, U., Norrheim, L., Larsen, A.E., Nesvold, A., Sandset, P.M. & Ødegaard, O.R. (1990) Monitoring therapy with LMW heparin: a comparison of three chromogenic substrate assays and the Heptest clotting assay. Haemostasis, 20, 193-203.
2. Barzu, T., Molho, P., Tobelem, G., Petitou, M. & Caen, J.P. (1984) Binding of heparin and low molecular weight heparin fragments to human vascular endothelial cells in culture. Nouvelle Revue Française d'Hématologie. 26, 243-247.
3. Bellusci, S., Moens, G., Gaudino, G., Comoglio. P., Nakamura, T., Thiery. J.P. & Jouanneau, J. (1994) Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene, 9, 1091-1099.
4. Borset, M., Hjorth-Hansen, H., Seidel, C., Sundan, A. & Waage, A. (1996a) Hepatocyte growth factor and its receptor c-met in multiple myeloma. Blood, 88, 3998-4004.
5. Borset, M., Lien, E., Espevik, T., Helseth, E., Waage, A. & Sundan, A. (1996b) Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines. Journal of Biological Chemistry, 271, 24655-24661.
6. Bottaro, D.P., Rubin, J.S.. Faletto, D.L., Chan, A.M., Kmiecik, T.E., Vande Woude, G.F. & Aaronson, S.A. (1991) Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science, 251, 802-804.
7. Bussolino, F., Di Renzo, M.F., Ziche, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A. & Comoglio. P.M. (1992) Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. Journal of Cell Biology. 119, 629-641.
8. Dahlman, T.C., Sjöberg, H.E. & Ringertz, H. (1994) Bone mineral density during long-term prophylaxis with heparin in pregnancy. American Journal of Obstetrics and Gynecology, 170, 1315-1320.
9. Douketis, J.D., Ginsberg, J.S., Burrows, R.F., Duku, E.K., Webber, C.E. & Brill Edwards, P. (1996) The effects of long-term heparin therapy during pregnancy on bone density: a prospective matched cohort study. Thrombosis and Haemostasis, 75, 254-257.
10. Fuller, K., Chambers, T.J. & Gallagher, A.C. (1991) Heparin augments osteoclast resorption-stimulating activity in serum. Journal of Cell Physiology, 147, 208-214.
11. Fuller, K., Owens, J. & Chambers, T.J. (1995) The effect of hepatocyte growth factor on the behaviour of osteoclasts. Biochemical and Biophysical Research Communications, 212, 334-340.
12. Grano, M., Galimi, F., Zambonin, G., Colucci, S., Cottone, E., Zallone, A.Z. & Comoglio, P.M. (1996) Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro. Proceedings of the National Academy of Sciences of the United States of America, 93, 7644-7648.
13. Hartmann, G., Prospero, T., Brinkmann, V., Ozcelik, O., Winter, G., Hepple, J., Batley, S., Bladt, F., Sachs, M., Birchmeier, C., Birchmeier, W. & Gherardi. E. (1998) Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo. Current Biology, 8, 125-134.
14. Hirsh, J. & Levine, M.N. (1992) Low molecular weight heparin. Blood, 79, 1-17.
15. Kato, Y., Liu, K.X., Nakamura, T. & Sugiyama, Y. (1994) Heparin-hepatocyte growth factor complex with low plasma clearance and retained hepatocyte proliferating activity. Hepatology, 20, 417-424.
16. Liu, K.X., Kato, Y. Kato, M., Kaku, T.I., Nakamura, T, & Sugiyama, Y. (1997) Existence of two nonlinear elimination mechanisms for hepatocyte growth factor in rats. American Journal of Physiology, 273, E891-E897.
17. Liu, K.X., Kato, Y., Narukawa, M., Kim, D.C., Hanano, M., Higuchi, O., Nakamura, T. & Sugiyama, Y. (1992) Importance of the liver in plasma clearance of hepatocyte growth factors in rats. American Journal of Physiology, 263, G642-G649.
18. Liu, K.X., Kato, Y., Terasaki. T., Aoki, S., Okumura, K., Nakamura, T. & Sugiyama, Y. (1995) Contribution of parenchymal and non-parenchymal liver cells to the clearance of hepatocyte growth factor from the circulation in rats. Pharmacological Research, 12, 1737-1740.
19. Lyon, M., Deakin, J.A., Mizuno, K., Nakamura, T. & Gallagher. J.T. (1994) Interaction of hepatocyte growth factor with heparan sulfate: elucidation of the major heparan sulfate structural determinants. Journal of Biological Chemistry, 269, 11216-11223.
20. Matsumoto, K. & Nakamura, T. (1996) Heparin functions as a hepatotrophic factor by inducing production of hepatocyte growth factor. Biochemical and Biophysical Research Communications, 227, 455-461.
21. Matsumoto, K., Tajima, H., Okazaki, H. & Nakamura, T. (1993) Heparin as an inducer of hepatocyte growth factor. Journal of Biochemistry, Tokyo, 114, 820-826.
22. Monreal, M., Vinas, L., Monreal, L., Lavin, S., Lafoz, E. & Angles, A.M. (1990) Heparin-related osteoporosis in rats: a comparative study between unfractioned heparin and a low-molecular-weight heparin. Haemostasis, 20, 204-207.
23. Muir, J.M., Hirsh, J., Weitz, J.I., Andrew, M., Young, E. & Shaughnessy, S.G. (1997) A histomorphometric comparison of the effects of heparin and low-molecular-weight heparin on cancellous bone in rats. Blood, 89, 3236-3242.
24. Murray, W.J., Lindo, V.S., Kakkar, V.V. & Melissari, E. (1995) Long-term administration of heparin and heparin fractions and osteoporosis in experimental animals. Blood Coagulation and Fibrinolysis, 6, 113-118.
25. Naka, D., Ishii, T., Shimomura, T., Hishida, T. & Hara, H. (1993) Heparin modulates the receptor-binding and mitogenic activity of hepatocyte growth factor on hepatocytes. Experimental Cell Research, 209, 317-324.
26. Sato, T., Hakeda, Y., Yamaguchi, Y., Mano, H., Tezuka, K., Matsumoto, K., Nakamura, T., Mori, Y., Yoshizawa, K., Sumitani, K., Kodama, A. & Kumegawa, M. (1995) Hepatocyte growth factor is involved in formation of osteoclast-like cells mediated by clonal stromal cells (MC3T3-G2/PA6). Journal of Cell Physiology, 164, 197-204.
27. Schwall, R.H., Chang, L.Y., Godowski, P.J., Kahn, D.W., Hillan, K.J., Bauer, K.D. & Zioncheck, T.F. (1996) Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2. Journal of Cell Biology, 133, 709-718.
28. Shaughnessy, S.G., Young, E., Deschamps, P. & Hirsh, J. (1995) The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria. Blood, 86, 1368-1373.
29. Shefras, J. & Farquharson, R.G. (1996) Bone density studies in pregnant women receiving heparin. European Journal of Obstetrics, Gynecology and Reproduction Biology, 65, 171-174.
30. Stoker, M., Gherardi, E., Perryman, M. & Gray, J. (1987) Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature, 327, 239-242.
31. Taniguchi, T., Toi, M. & Tominaga, T. (1994) Rapid induction of hepatocyte growth factor by heparin. (Letter). Lancet, 344, 470.
32. van Rijn, J.L., Trillou, M., Mardiguian. J.. Tobelem, G. & Caen, J. (1987) Selective binding of heparins to human endothelial cells: implications for pharmacokinetics. Thrombosis Research, 45, 211-222.
33. Weidner, K.M., Behrens, J., Vandekerckhove, J. & Birchmeier, W. (1990) Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. Journal of Cell Biology, 111, 2097-2108.
34. Yamazaki, H., Oi, H., Matsumoto, K., Matsushita, M., Ozeki, S., Teshima, T., Murayama, S., Inoue, T. & Nakamura, T. (1996) Biphasic changes in serum hepatocyte growth factor after transarterial chemoembolization therapy for hepato-cellular carcinoma. Cytokine, 8, 178-182.
35. Yamazaki. H., Oi, H., Matsushita, M., Inoue, T., Tang, J.T., Nose, T., Koizumi, M., Tanaka, E., Teshima, T., Ozeki, S. & Nakamura, H. (1997) Heparin induces rapid and remarkable elevation of hepatocyte growth factor/scatter factor during trans-arterial embolization of renal cell carcinoma. Anticancer Research, 17, 1435-1437.
36. Young, E., Prins, M., Levine, M.N. & Hirsh, J. (1992) Heparin binding to plasma proteins, an important mechanism for heparin resistance. Thrombosis and Haemostasis, 67, 639-643.
37. Zarnegar, R., DeFrances, M.C., Oliver, L. & Michalopoulos, G. (1990) Identification and partial characterization of receptor binding sites for HGF on rat hepatocytes. Biochemical and Biophysical Research Communications, 173, 1179-1185.
38. Zarnegar, R. & Michalopoulos, G.K. (1995) The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. Journal of Cell Biology, 129, 1177-1180.
39. Zioncheck, T.F., Richardson, L, DeGuzman, G.G., Modi, N.B., Hansen, S.E. & Godowski, P.J. (1994) The pharmacokinetics, tissue localization, and metabolic processing of recombinant human hepatocyte growth factor after intravenous administration in rats. Endocrinology, 134, 1879-1887.
40. Zioncheck, T.F., Richardson, L., Liu, J., Chang, L., King, K.L., Bennett, G.L., Pugedi, P., Chamow, S.M., Schwall, R.H. & Stack, R.J. (1995) Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity. Journal of Biological Chemistry, 270, 16871-16878.